Publication date: Jul 06, 2023
The COVID-19 pandemic has impacted the world that was not previously conceivable. In early 2020, hospitals on all continents were overwhelmed with patients afflicted with this novel virus, with unanticipated mortality worldwide. The virus has had a deleterious effect, particularly the respiratory and cardiovascular systems. Cardiovascular biomarkers demonstrated an array of cardiovascular insults from hypoxia to inflammatory and perfusion abnormalities of the myocardium to life-threatening arrhythmias and heart failure. Patients were at increased risk of a pro-thrombotic state early in the course of the disease. Cardiovascular imaging became a primary tool in diagnosing, prognosing and risk-stratifying patients. TTE became the initial imaging modality in management of cardiovascular implications. In addition to cardiac function, LV longitudinal strain (LVLS) and right ventricular free wall strain (RVFWS) were indicators of increased morbidly and mortality. Cardiac MRI has become the diagnostic cardiovascular imaging for myocardial injury and tissue evaluation in the age of COVID-19.
| Concepts | Keywords |
|---|---|
| Biomarkers | Cardiac |
| Hospitals | Cardiovascular |
| Myocardial | Complications |
| Virus | Covid |
| Early | |
| Era | |
| Imaging | |
| Impacted | |
| Increased | |
| Mortality | |
| Pandemic | |
| Present | |
| Risk | |
| Strain | |
| Virus |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Complications |
| disease | MESH | COVID-19 Pandemic |
| disease | MESH | abnormalities |
| disease | MESH | heart failure |